- •Hematuria II: causes and investigation
- •Hematospermia
- •Lower urinary tract symptoms (LUTS)
- •Nocturia and nocturnal polyuria
- •Flank pain
- •Urinary incontinence in adults
- •Genital symptoms
- •Abdominal examination in urological disease
- •Digital rectal examination (DRE)
- •Lumps in the groin
- •Lumps in the scrotum
- •2 Urological investigations
- •Urine examination
- •Urine cytology
- •Radiological imaging of the urinary tract
- •Uses of plain abdominal radiography (KUB X-ray—kidneys, ureters, bladder)
- •Intravenous pyelography (IVP)
- •Other urological contrast studies
- •Computed tomography (CT) and magnetic resonance imaging (MRI)
- •Radioisotope imaging
- •Post-void residual urine volume measurement
- •3 Bladder outlet obstruction
- •Regulation of prostate growth and development of benign prostatic hyperplasia (BPH)
- •Pathophysiology and causes of bladder outlet obstruction (BOO) and BPH
- •Benign prostatic obstruction (BPO): symptoms and signs
- •Diagnostic tests in men with LUTS thought to be due to BPH
- •Why do men seek treatment for their symptoms?
- •Watchful waiting for uncomplicated BPH
- •Medical management of BPH: combination therapy
- •Medical management of BPH: alternative drug therapy
- •Minimally invasive management of BPH: surgical alternatives to TURP
- •Invasive surgical alternatives to TURP
- •TURP and open prostatectomy
- •Indications for and technique of urethral catheterization
- •Indications for and technique of suprapubic catheterization
- •Management of nocturia and nocturnal polyuria
- •High-pressure chronic retention (HPCR)
- •Bladder outlet obstruction and retention in women
- •Urethral stricture disease
- •4 Incontinence
- •Causes and pathophysiology
- •Evaluation
- •Treatment of sphincter weakness incontinence: injection therapy
- •Treatment of sphincter weakness incontinence: retropubic suspension
- •Treatment of sphincter weakness incontinence: pubovaginal slings
- •Overactive bladder: conventional treatment
- •Overactive bladder: options for failed conventional therapy
- •“Mixed” incontinence
- •Post-prostatectomy incontinence
- •Incontinence in the elderly patient
- •Urinary tract infection: microbiology
- •Lower urinary tract infection
- •Recurrent urinary tract infection
- •Urinary tract infection: treatment
- •Acute pyelonephritis
- •Pyonephrosis and perinephric abscess
- •Other forms of pyelonephritis
- •Chronic pyelonephritis
- •Septicemia and urosepsis
- •Fournier gangrene
- •Epididymitis and orchitis
- •Periurethral abscess
- •Prostatitis: presentation, evaluation, and treatment
- •Other prostate infections
- •Interstitial cystitis
- •Tuberculosis
- •Parasitic infections
- •HIV in urological surgery
- •6 Urological neoplasia
- •Pathology and molecular biology
- •Prostate cancer: epidemiology and etiology
- •Prostate cancer: incidence, prevalence, and mortality
- •Prostate cancer pathology: premalignant lesions
- •Counseling before prostate cancer screening
- •Prostate cancer: clinical presentation
- •PSA and prostate cancer
- •PSA derivatives: free-to-total ratio, density, and velocity
- •Prostate cancer: transrectal ultrasonography and biopsies
- •Prostate cancer staging
- •Prostate cancer grading
- •General principles of management of localized prostate cancer
- •Management of localized prostate cancer: watchful waiting and active surveillance
- •Management of localized prostate cancer: radical prostatectomy
- •Postoperative course after radical prostatectomy
- •Prostate cancer control with radical prostatectomy
- •Management of localized prostate cancer: radical external beam radiotherapy (EBRT)
- •Management of localized prostate cancer: brachytherapy (BT)
- •Management of localized and radiorecurrent prostate cancer: cryotherapy and HIFU
- •Management of locally advanced nonmetastatic prostate cancer (T3–4 N0M0)
- •Management of advanced prostate cancer: hormone therapy I
- •Management of advanced prostate cancer: hormone therapy II
- •Management of advanced prostate cancer: hormone therapy III
- •Management of advanced prostate cancer: androgen-independent/ castration-resistant disease
- •Palliative management of prostate cancer
- •Prostate cancer: prevention; complementary and alternative therapies
- •Bladder cancer: epidemiology and etiology
- •Bladder cancer: pathology and staging
- •Bladder cancer: presentation
- •Bladder cancer: diagnosis and staging
- •Muscle-invasive bladder cancer: surgical management of localized (pT2/3a) disease
- •Muscle-invasive bladder cancer: radical and palliative radiotherapy
- •Muscle-invasive bladder cancer: management of locally advanced and metastatic disease
- •Bladder cancer: urinary diversion after cystectomy
- •Transitional cell carcinoma (UC) of the renal pelvis and ureter
- •Radiological assessment of renal masses
- •Benign renal masses
- •Renal cell carcinoma: epidemiology and etiology
- •Renal cell carcinoma: pathology, staging, and prognosis
- •Renal cell carcinoma: presentation and investigations
- •Renal cell carcinoma: active surveillance
- •Renal cell carcinoma: surgical treatment I
- •Renal cell carcinoma: surgical treatment II
- •Renal cell carcinoma: management of metastatic disease
- •Testicular cancer: epidemiology and etiology
- •Testicular cancer: clinical presentation
- •Testicular cancer: serum markers
- •Testicular cancer: pathology and staging
- •Testicular cancer: prognostic staging system for metastatic germ cell cancer
- •Testicular cancer: management of non-seminomatous germ cell tumors (NSGCT)
- •Testicular cancer: management of seminoma, IGCN, and lymphoma
- •Penile neoplasia: benign, viral-related, and premalignant lesions
- •Penile cancer: epidemiology, risk factors, and pathology
- •Squamous cell carcinoma of the penis: clinical management
- •Carcinoma of the scrotum
- •Tumors of the testicular adnexa
- •Urethral cancer
- •Wilms tumor and neuroblastoma
- •7 Miscellaneous urological diseases of the kidney
- •Cystic renal disease: simple cysts
- •Cystic renal disease: calyceal diverticulum
- •Cystic renal disease: medullary sponge kidney (MSK)
- •Acquired renal cystic disease (ARCD)
- •Autosomal dominant (adult) polycystic kidney disease (ADPKD)
- •Ureteropelvic junction (UPJ) obstruction in adults
- •Anomalies of renal ascent and fusion: horseshoe kidney, pelvic kidney, malrotation
- •Renal duplications
- •8 Stone disease
- •Kidney stones: epidemiology
- •Kidney stones: types and predisposing factors
- •Kidney stones: mechanisms of formation
- •Evaluation of the stone former
- •Kidney stones: presentation and diagnosis
- •Kidney stone treatment options: watchful waiting
- •Stone fragmentation techniques: extracorporeal lithotripsy (ESWL)
- •Intracorporeal techniques of stone fragmentation (fragmentation within the body)
- •Kidney stone treatment: percutaneous nephrolithotomy (PCNL)
- •Kidney stones: open stone surgery
- •Kidney stones: medical therapy (dissolution therapy)
- •Ureteric stones: presentation
- •Ureteric stones: diagnostic radiological imaging
- •Ureteric stones: acute management
- •Ureteric stones: indications for intervention to relieve obstruction and/or remove the stone
- •Ureteric stone treatment
- •Treatment options for ureteric stones
- •Prevention of calcium oxalate stone formation
- •Bladder stones
- •Management of ureteric stones in pregnancy
- •Hydronephrosis
- •Management of ureteric strictures (other than UPJ obstruction)
- •Pathophysiology of urinary tract obstruction
- •Ureter innervation
- •10 Trauma to the urinary tract and other urological emergencies
- •Renal trauma: clinical and radiological assessment
- •Renal trauma: treatment
- •Ureteral injuries: mechanisms and diagnosis
- •Ureteral injuries: management
- •Bladder and urethral injuries associated with pelvic fractures
- •Bladder injuries
- •Posterior urethral injuries in males and urethral injuries in females
- •Anterior urethral injuries
- •Testicular injuries
- •Penile injuries
- •Torsion of the testis and testicular appendages
- •Paraphimosis
- •Malignant ureteral obstruction
- •Spinal cord and cauda equina compression
- •11 Infertility
- •Male reproductive physiology
- •Etiology and evaluation of male infertility
- •Lab investigation of male infertility
- •Oligospermia and azoospermia
- •Varicocele
- •Treatment options for male factor infertility
- •12 Disorders of erectile function, ejaculation, and seminal vesicles
- •Physiology of erection and ejaculation
- •Impotence: evaluation
- •Impotence: treatment
- •Retrograde ejaculation
- •Peyronie’s disease
- •Priapism
- •13 Neuropathic bladder
- •Innervation of the lower urinary tract (LUT)
- •Physiology of urine storage and micturition
- •Bladder and sphincter behavior in the patient with neurological disease
- •The neuropathic lower urinary tract: clinical consequences of storage and emptying problems
- •Bladder management techniques for the neuropathic patient
- •Catheters and sheaths and the neuropathic patient
- •Management of incontinence in the neuropathic patient
- •Management of recurrent urinary tract infections (UTIs) in the neuropathic patient
- •Management of hydronephrosis in the neuropathic patient
- •Bladder dysfunction in multiple sclerosis, in Parkinson disease, after stroke, and in other neurological disease
- •Neuromodulation in lower urinary tract dysfunction
- •14 Urological problems in pregnancy
- •Physiological and anatomical changes in the urinary tract
- •Urinary tract infection (UTI)
- •Hydronephrosis
- •15 Pediatric urology
- •Embryology: urinary tract
- •Undescended testes
- •Urinary tract infection (UTI)
- •Ectopic ureter
- •Ureterocele
- •Ureteropelvic junction (UPJ) obstruction
- •Hypospadias
- •Normal sexual differentiation
- •Abnormal sexual differentiation
- •Cystic kidney disease
- •Exstrophy
- •Epispadias
- •Posterior urethral valves
- •Non-neurogenic voiding dysfunction
- •Nocturnal enuresis
- •16 Urological surgery and equipment
- •Preparation of the patient for urological surgery
- •Antibiotic prophylaxis in urological surgery
- •Complications of surgery in general: DVT and PE
- •Fluid balance and management of shock in the surgical patient
- •Patient safety in the operating room
- •Transurethral resection (TUR) syndrome
- •Catheters and drains in urological surgery
- •Guide wires
- •JJ stents
- •Lasers in urological surgery
- •Diathermy
- •Sterilization of urological equipment
- •Telescopes and light sources in urological endoscopy
- •Consent: general principles
- •Cystoscopy
- •Transurethral resection of the prostate (TURP)
- •Transurethral resection of bladder tumor (TURBT)
- •Optical urethrotomy
- •Circumcision
- •Hydrocele and epididymal cyst removal
- •Nesbit procedure
- •Vasectomy and vasovasostomy
- •Orchiectomy
- •Urological incisions
- •JJ stent insertion
- •Nephrectomy and nephroureterectomy
- •Radical prostatectomy
- •Radical cystectomy
- •Ileal conduit
- •Percutaneous nephrolithotomy (PCNL)
- •Ureteroscopes and ureteroscopy
- •Pyeloplasty
- •Laparoscopic surgery
- •Endoscopic cystolitholapaxy and (open) cystolithotomy
- •Scrotal exploration for torsion and orchiopexy
- •17 Basic science of relevance to urological practice
- •Physiology of bladder and urethra
- •Renal anatomy: renal blood flow and renal function
- •Renal physiology: regulation of water balance
- •Renal physiology: regulation of sodium and potassium excretion
- •Renal physiology: acid–base balance
- •18 Urological eponyms
- •Index
476 CHAPTER 11 Infertility
Oligospermia and azoospermia
Oligospermia
Oligospermia is defined as a sperm concentration of <20 million/mL of ejaculate.
Etiology
It is often idiopathic. It is identified in ~60% of patients presenting with testicular cancer or lymphoma.
Associated disorders
It is often associated with abnormalities of morphology and motility (oligoasthenoteratospermia). Common causes include varicoceles, cryptorchidism, idiopathic, drug and toxin exposure, and febrile illness.
Investigations
Semen analysis: Severely low sperm counts (<5–10 million/mL) require hormone investigation, including FSH and testosterone. Severe oligospermia is associated with seminiferous tubular failure, small soft testes, and iFSH.
Treatment
Correct the underlying cause. Idiopathic cases may respond to empirical medical therapy. Clomiphene and tamoxifen are mild antiestrogens that work best for men with low to normal testosterone and FSH levels.
Consider assisted reproductive techniques, such as intrauterine insemination (IUI) or intracytoplasmic sperm injection (ICSI).
Azoospermia
This is defined as a complete absence of sperm in the ejaculate fluid.
Etiology
•Obstructive: absent or obstructed vas deferens; epididymal or ejaculatory duct obstruction. The cystic fibrosis gene is located on chromosome 7 and the condition is associated with congenital absence of the vas deferens (CAVD).
•Nonobstructive: hypogonadotrophism (Kallmann’s syndrome, pituitary tumour); abnormalities of spermatogenesis (chromosomal anomalies, toxins, idiopathic, varicocele, orchitis, testicular torsion)
Investigations
Hormone assay
Elevated FSH indicates a nonobstructive cause; normal FSH with normal testes indicates an increased likelihood of obstruction. Low levels of FSH, LH, and testosterone indicate Kallmann’s syndrome (hypogonadotropic hypogonadism) due to hypothalamic dysfunction and absence of GnRH secretion.
Prader-Willi syndrome also has absent GnRH secretion. It is associated with obesity, mental retardation, and short stature, whereas Kallman’s syndrome is associated with anosmia.
OLIGOSPERMIA AND AZOOSPERMIA 477
Chromosomal analysis
This may be used to exclude Kleinfelter’s syndrome in patients presenting with azoospermia, small soft testes, gynecomastia, iFSH/LH, and dtestosterone.
Testicular biopsy
This is best performed as an open procedure. It is performed to assess if normal sperm maturation is occurring and for sperm retrieval (for later therapeutic use).
Diagnostic biopsy is indicated in azoospermic men with testes of normal size and consistency, palpable vasa deferentia, and normal FSH levels. Biospy may also be therapeutic, since sperm can be retrieved on testis biopsy from 25–50% of patients with Sertoli cell only syndrome, and 50–75% of men with maturation arrest. Multiple sample sites are performed if sperm are not immediately obtained.
Transrectal ultrasound
This is indicated for low semen volume to assess for ejaculatory duct obstruction. Men with ejaculatory duct obstruction will tend to have low semen volume and fructose, and semen pH <7.
Management
Treatment will depend on the underlying etiology.
•Transurethral resection of ejaculatory ducts (TURED) is associated with improved semen quality in 52%.
•Bilateral absence or agenesis of vas deferens: microsurgical epididymal sperm aspiration (MESA), or consider artificial insemination using donor (AID).
•Primary testicular failure with testicular atrophy: testicular sperm extraction (TESE); in vitro fertilization (IVF); or consider AID.
•Primary testicular failure with normal testis: TESE; IVF; AID
•Obstructive cause with normal testis: epididymovasostomy; vasovasostomy
478 CHAPTER 11 Infertility
Varicocele
Definition
Varicocele is dilatation of the veins of the pampiniform plexus of the spermatic cord.
Prevalence
This is the most common correctable cause of male infertility. Varicocele is found in 15% of men in the general population and 40% of males presenting with infertility. Bilateral or unilateral (left side affected in 90%).
Etiology
Incompetent values in the internal spermatic veins lead to retrograde blood flow, vessel dilatation, and tortuosity of the pampiniform plexus. The left internal spermatic vein enters the renal vein at a right angle, creating a column of blood that is under a higher pressure than that in the right vein, which enters the vena cava obliquely at a lower level. As a consequence, the left side is more likely to develop a varicocele.
Pathophysiology
Testicular venous drainage is via the pampiniform plexus, a meshwork of veins encircling the testicular arteries. This arrangement normally provides a countercurrent heat exchange mechanism that cools arterial blood as it reaches the testis. Varicoceles adversely affect this mechanism, resulting in elevated scrotal temperatures and consequent deleterious effects on spermatogenesis (± loss of testicular volume).
Varicocele grading system
|
|
Grade |
Size |
Definition |
|
1 |
Small |
Palpable only with Valsalva maneuver |
|
|
2 |
Moderate |
Palpable in a standing position |
|
|
|
|||
|
3 |
Large |
Visible through the scrotal skin |
|
|
|
|
|
|
Presentation
The majority of varicoceles are asymptomatic, although large varicoceles may cause pain or a heavy feeling in the scrotal area. Examine patient both lying and standing, and ask patient to perform Valsalva maneuver (strain down).
A varicocele is identified as a mass of dilated and tortuous veins above the testicle (described as feeling like a “bag of worms”), which decompress on lying supine. Examine for testicular atrophy, which is often associated with chronic testicular injury.
Investigation
•Scrotal Doppler ultrasound scan is diagnostic.
•Semen analysis: Varicoceles are associated with reduced sperm counts and motility, and abnormal morphology, either alone or in combination (oligoasthenoteratospermia).
VARICOCELE 479
Management
Surgical ligation
•Retroperitoneal approach: A muscle-splitting incision is made near the anterior superior iliac spine, and the spermatic vessels are ligated at that level.
•Inguinal approach: The inguinal canal is incised to access the spermatic cord, and the veins are tied off as they exit the internal ring.
•Subinguinal approach: Veins are accessed and ligated via a small transverse incision below the external ring.
•Laparoscopic: Veins are occluded high in the retroperitoneum.
Surgical complications include varicocele recurrence, hydrocele formation, and testicular infarction and atrophy.
Surgical outcome
There is a 95% success rate; 70% of men have improvement of sperm parameters—most often motility, followed by count and then morphology. Testicular growth is often impaired in adolescents with varicoceles, but surgical repair may result in catch-up growth.
Embolization
In this interventional radiological technique, the femoral vein is used to access the spermatic vein for venography and embolization (with coils or other sclerosing agents).